innovation delivered
The Diagnostyx team has been focused on developing a class of smart delivery devices for a variety of liquid therapeutics.
We are currently in stealth mode.
“Other competing T2D drug delivery platforms have one or more ‘fatal flaws’ and therefore Diagnostyx platform represents the best in class pump architecture.”
Mark Anderson, Sanofi, Senior Principle Engineer 2016
“The Diagnostyx team executed exemplary work above and beyond the norms of Lilly subcontractors in supporting our MoAB injector platform.”
Bob Nesbit, Eli Lilly, Director of Advanced Development and Research, Devices 2013